The PREVENT program is a peer-reviewed agent development program designed to support preclinical development of innovative interventions and biomarkers for cancer prevention and interception towards clinical trials. All interested researchers with novel concepts are eligible to apply. PREVENT is not a grant program, but allocates NCI contract resources and expertise to generate data and materials, which are used by the applicants for further development. PREVENT’s current research priority areas include immunoprevention, chemoprevention, and clinically translatable biomarkers.
Read more About PREVENT.
Submission deadlines occur twice per year on the second Monday in January and July.
Extended deadline: Monday, July 8, 2024
Instructions for Applying
Please use the latest
131 Projects from PREVENT Cycles 1 through 24:
- 79 Chemoprevention projects
- 43 Immunoprevention projects
- 9 Biomarker projects
Read more about supported projects and supported prevention approaches.
- Regulatory Support
- Current Good Manufacturing Practice (CGMP)
- DCP Repository
- Governance Structure
- Technology Transfer Considerations